Filing Details

Accession Number:
0001683168-24-000161
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-09 17:31:41
Reporting Period:
2024-01-05
Accepted Time:
2024-01-09 17:31:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759186 Coeptis Therapeutics Holdings Inc. COEP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1592481 Gene Salkind 105 Bradford Road
Suite 420
Wexford PA 15090
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-05 11,600 $0.69 284,056 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 28,638 Indirect By Trust
Common Stock 4,046 Indirect By Trust
Footnotes
  1. Includes (i) 95,817 shares of common stock that are held as JTWROS with Catherine Salkind, (ii) 57,268 shares of common stock issuableupon exercise of currently exercisable warrants held as JTWROS with Catherine Salkind, (iii) 101,061 shares of common stock that areissuable upon currently exercisable warrants and (iv) 30,000 shares of common stock that are issuable upon exercise of options that are or willbecome exercisable in the next 60 days.
  2. These shares were not subject to a particular transaction during the dates covered by this Form 4 and are listed here to disclose the Reporting Person's holdings as required by Securities and Exchange Commission rules.
  3. The Marital Trust GST Subject U/W/O Leopold Salkind, for which the Reporting Person is the Trustee.
  4. Julian R Salkind Trust DTD 10/11/94, for which the Reporting Person is the Trustee.